BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Suletud

SektorKinnisvara

31.64 1.74

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

31.08

Max

32.3

Põhinäitajad

By Trading Economics

Sissetulek

153M

Müük

951M

P/E

Sektori keskmine

143.238

78.251

Aktsiakasum

0.26

Dividenditootlus

1.28

Kasumimarginaal

16.106

Töötajad

6,978

EBITDA

276M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+20.64% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.28%

5.61%

Järgmine tulemuste avaldamine

28. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-4.4B

18B

Eelmine avamishind

29.9

Eelmine sulgemishind

31.64

Uudiste sentiment

By Acuity

62%

38%

158 / 192 Pingereas Real estate

Fisher & Paykel Healthcare Corp Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. veebr 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2. veebr 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28. nov 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18. nov 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2. sept 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30. mai 2024, 00:44 UTC

Market Talk
Tulu

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29. mai 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28. mai 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28. mai 2024, 20:59 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28. mai 2024, 20:58 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28. mai 2024, 20:57 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28. mai 2024, 20:56 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24. apr 2024, 02:38 UTC

Market Talk

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Fisher & Paykel Healthcare Corp Ltd Prognoos

Hinnasiht

By TipRanks

20.64% tõus

12 kuu keskmine prognoos

Keskmine 36.495 AUD  20.64%

Kõrge 42.7 AUD

Madal 31.95 AUD

Põhineb 6 Wall Streeti analüütiku instrumendi Fisher & Paykel Healthcare Corp Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

2

Osta

2

Hoia

2

Müü

Sentiment

By Acuity

158 / 192 Pingereas Kinnisvara

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.